Parkinsonian symptoms as an initial manifestation in a Japanese patient with acquired immunodeficiency syndrome and Toxoplasma infection

Internal Medicine

Volumn 39, Issue 12, 2000, Pages 1111-1114

  Murakami, Tatsufumi ^a,c   Nakajima, Makoto ^a   Nakamura, Tahei ^b   Hara, Akio ^a   Uyama, Eiichiro ^a   Mita, Shuji ^a   Matsushita, Shuzo ^b   Uchino, Makoto ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Highly active antiretroviral therapy; Toxoplasmosis

Indexed keywords

ANTIPROTOZOAL AGENT; CARBIDOPA; LEVODOPA; PYRIMETHAMINE;

AIDS RELATED COMPLEX; CASE REPORT; CORPUS STRIATUM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASITOLOGY; PARIETAL LOBE; PARKINSONISM; PATHOLOGY; REVIEW; SYPHILIS; TOXOPLASMOSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIPROTOZOAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CARBIDOPA; CORPUS STRIATUM; HUMANS; LEVODOPA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARIETAL LOBE; PARKINSONIAN DISORDERS; PYRIMETHAMINE; SYPHILIS; TOXOPLASMOSIS, CEREBRAL;

EID: 0034567958     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.39.1111     Document Type: Article

References (11)

1. Nath A, Jankovic J, Pettigrew LC. Movement disorders and AIDS. Neurology 37: 37-41, 1987.
2. Carrazana EJ, Rossitch E Jr, Samuels MA. Parkinsonian symptoms in a patient with AIDS and cerebral toxoplasmosis. J Neurol Neurosurg Psychiatry 52: 1445-1447, 1989 (letter).
3. Noël S, Guillaume M-P, Telerman-Toppet N, Cogan E. Movement disorders due to cerebral Toxoplasma gondii infection in patients with the acquired immnodeficiency syndrome (AIDS). Acta Neurol Belg 92: 148-156, 1992.
4. Hollander H, Levy JA. Neurologic abnormalities and recovery of human immunodeficiency virus from cerebrospinal fluid. Ann Intern Med 106: 692-695, 1987.
5. Nakagawa M, Maruyama Y, Sugita H, Osame M. Nationwide survey of neurologic manifestations of acquired immunodeficiency syndrome in Japan. Intern Med 36: 175-178, 1997.
6. Navia BA, Petito CK, Gold JWM, Cho E-S, Jordan BD, Price RW. Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients. Ann Neurol 19: 224-238, 1986.
7. Cimino C, Lipton RB, Williams A, Feraru E, Harris C, Hirschfeld A. The evaluation of patients with human immunodeficiency virus-related disorders and brain mass lesions. Arch Intern Med 151: 1381-1384, 1991.
8. Berger JR, Waskin H, Pall L, Hensley G, Ihmedian I, Post MJD. Syphilitic cerebral gumma with HIV infection. Neurology 42: 1282-1287, 1992.
9. Mirsattari SM, Power C, Nath A. Parkinsonism with HIV infection. Mov Disord 13: 684-689, 1998.
10. Palella FJ Jr, Delaney KM, Moorman AC, et al, and HIV Outpatient Study Investigators. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 338: 853-860, 1998.
11. Clifford DB, Yiannoutsos C, Glicksman M, et al. HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 52: 623-625, 1999.